(Q79206151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

The free-to-total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Erim Erdem

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Necmettin Atsü

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Cem Akbal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Cenk Y Bilen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ali Ergen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Haluk Ozen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

International Urology and Nephrology

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

519-523

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

20 December 2019

cites work

1 reference

12 December 2020

The free-to-total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer

1 reference

12 December 2020

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

12 December 2020

Prediction of capsular perforation and seminal vesicle invasion in prostate cancer

1 reference

12 December 2020

Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate

1 reference

12 December 2020

Utility of preoperative serumprostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer

1 reference

12 December 2020

Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy

1 reference

12 December 2020

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

12 December 2020

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial

1 reference

12 December 2020

Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer

1 reference

12 December 2020

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

12 December 2020

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

12 December 2020

Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1025685718493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14577496%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference